Objective: To probe into the role of clinical pharmacists in the therapy for pediatric refractory Mycoplasma pneumoniae pneumonia complicated with pulmonary embolism

so as to provide reference for the medication and pharmaceutical care of pulmonary embolism in pediatrics. Methods: Clinical pharmacists participated into the treatment of a child with refractory Mycoplasma pneumoniae pneumonia complicated with pulmonary embolism

assisted the clinicians to adjust the treatment regimens. Meanwhile

individualized pharmaceutical care was provided for the child and medication education of key drugs was performed

so as to ensure the efficacy and reduce adverse drug reactions. Results: Through the pharmaceutical care provided by clinical pharmacists

the safety and effectiveness of medication were improved and adverse drug reactions were avoided as far as possible. Conclusion: The implementation of pharmaceutical care by clinical pharmacists can coordinate the optimization of treatment regimens

which is conducive to the safety and effectiveness of medications for children.